Allstate (NYSE:ALL) Releases Earnings Results, Beats Estimates By $1.71 EPS

Allstate (NYSE:ALLGet Free Report) announced its quarterly earnings data on Wednesday. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71, Briefing.com reports. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The firm had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. During the same period last year, the firm earned $0.81 earnings per share. The company’s revenue for the quarter was up 14.7% compared to the same quarter last year.

Allstate Stock Performance

NYSE:ALL traded down $2.92 during trading hours on Thursday, reaching $186.52. The company had a trading volume of 3,902,110 shares, compared to its average volume of 1,546,806. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49. Allstate has a 52 week low of $125.63 and a 52 week high of $198.79. The firm has a market cap of $49.23 billion, a price-to-earnings ratio of 41.69, a PEG ratio of 1.74 and a beta of 0.48. The firm’s 50 day moving average price is $188.69 and its 200-day moving average price is $174.95.

Insiders Place Their Bets

In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares of the company’s stock, valued at $5,236,922.32. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert Toohey sold 16,682 shares of the business’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the sale, the executive vice president now directly owns 4,873 shares of the company’s stock, valued at approximately $877,968.41. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 192,530 shares of company stock valued at $34,967,665. Company insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on ALL shares. Roth Mkm reaffirmed a “buy” rating and set a $200.00 price objective on shares of Allstate in a research note on Wednesday, August 14th. Jefferies Financial Group raised their target price on Allstate from $217.00 to $231.00 and gave the stock a “buy” rating in a research note on Wednesday, October 9th. Bank of America raised their target price on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. JPMorgan Chase & Co. raised their target price on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. Finally, BMO Capital Markets raised their target price on Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $207.19.

View Our Latest Analysis on Allstate

About Allstate

(Get Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Read More

Earnings History for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.